Clinical Trials Insight: 700051064
Not yet recruiting
Phase of Trial: Phase I
Latest Information Update: 17 Nov 2009
At a glance
- Drugs ARG 301 (Primary)
- Indications Rheumatoid arthritis
- Focus Therapeutic Use
- Sponsors arGentis Pharmaceuticals
- 17 Nov 2009 New trial record.
- 13 Nov 2009 arGentis Pharmaceuticals will collaberate with the University of Tennessee Health Science Center and the Veterans Affairs Medical Center of Mephis to initiate this trial, according to a arGentis Pharmaceuticals media release.